Company Filing History:
Years Active: 2002
Title: Innovations of Inventor Hernán A Navarro
Introduction
Hernán A Navarro is a notable inventor located in Chapel Hill, North Carolina, recognized for his contributions to the field of neuroscience. His innovative work focuses on the development of novel ligands for α-7 nicotinic acetylcholine receptors, which have significant implications for the detection and treatment of central nervous system diseases, including Alzheimer's.
Latest Patents
Navarro holds a patent that details "Ligands for α-7 nicotinic acetylcholine receptors based on methyllcaconitine." This patent outlines various derivatives of methyllycaconitine (MLA), such as radiolabeled MLA and MLA containing a fluorimetric marker group. These ligands are designed for imaging purposes to detect Alzheimer's and other CNS diseases. Additionally, the patent discusses combinatorial assays for identifying compounds with affinity for nAChRs and highlights injectable compositions and kits that facilitate imaging studies.
Career Highlights
Hernán A Navarro has built a successful career at the Research Triangle Institute, where his research contributes to ground-breaking advancements in pharmaceutical and medical science. His work is characterized by a strong emphasis on improving the methodologies for detecting critical neurodegenerative conditions.
Collaborations
Throughout his career, Navarro has collaborated with esteemed colleagues, including Frank Ivy Carroll and Philip Abraham. These partnerships have been instrumental in advancing research efforts and fostering innovative solutions in the field of neurosciences.
Conclusion
Hernán A Navarro stands out as a pivotal figure in the development of treatments for CNS diseases through his innovative patent contributions. His work not only enriches the scientific community but also holds the potential for significant impacts on patient care and diagnostics in the realm of neurology.